E
Universal Ibogaine Inc.
IBO.V
TSX
E
Sell
1/21/2025Downgrade
Universal Ibogaine Inc. (IBO.V) was downgraded to E+ from D- on 1/21/2025 due to a decline in the valuation index and volatility index.
Universal Ibogaine Inc. (IBO.V) was downgraded to E+ from D- on 1/21/2025 due to a decline in the valuation index and volatility index.
D
Sell
1/6/2025Upgraded
Universal Ibogaine Inc. (IBO.V) was upgraded to D- from E+ on 1/6/2025 due to an increase in the valuation index, total return index and volatility index.
Universal Ibogaine Inc. (IBO.V) was upgraded to D- from E+ on 1/6/2025 due to an increase in the valuation index, total return index and volatility index.
E
Sell
10/9/2024Downgrade
Universal Ibogaine Inc. (IBO.V) was downgraded to E+ from D- on 10/9/2024 due to a decline in the valuation index.
Universal Ibogaine Inc. (IBO.V) was downgraded to E+ from D- on 10/9/2024 due to a decline in the valuation index.
D
Sell
9/24/2024Upgraded
Universal Ibogaine Inc. (IBO.V) was upgraded to D- from E+ on 9/24/2024 due to an increase in the volatility index and total return index.
Universal Ibogaine Inc. (IBO.V) was upgraded to D- from E+ on 9/24/2024 due to an increase in the volatility index and total return index.
E
Sell
9/9/2024Downgrade
Universal Ibogaine Inc. (IBO.V) was downgraded to E+ from D- on 9/9/2024 due to a decline in the volatility index and total return index.
Universal Ibogaine Inc. (IBO.V) was downgraded to E+ from D- on 9/9/2024 due to a decline in the volatility index and total return index.
D
Sell
8/23/2024Upgraded
Universal Ibogaine Inc. (IBO.V) was upgraded to D- from E+ on 8/23/2024 due to an increase in the total return index and volatility index.
Universal Ibogaine Inc. (IBO.V) was upgraded to D- from E+ on 8/23/2024 due to an increase in the total return index and volatility index.
E
Sell
7/11/2024Downgrade
Universal Ibogaine Inc. (IBO.V) was downgraded to E+ from D- on 7/11/2024 due to a significant decline in the growth index, total return index and volatility index. Operating cash flow declined 632.94% from -$50.4 to -$369.4, earnings per share declined from -$0.0009 to -$0.0022, and EBIT declined 131.57% from -$138.1 to -$319.8.
Universal Ibogaine Inc. (IBO.V) was downgraded to E+ from D- on 7/11/2024 due to a significant decline in the growth index, total return index and volatility index. Operating cash flow declined 632.94% from -$50.4 to -$369.4, earnings per share declined from -$0.0009 to -$0.0022, and EBIT declined 131.57% from -$138.1 to -$319.8.
D
Sell
4/11/2024Upgraded
Universal Ibogaine Inc. (IBO.V) was upgraded to D- from E+ on 4/11/2024 due to a large increase in the total return index, growth index and volatility index. Operating cash flow increased 62.89% from -$135.8 to -$50.4.
Universal Ibogaine Inc. (IBO.V) was upgraded to D- from E+ on 4/11/2024 due to a large increase in the total return index, growth index and volatility index. Operating cash flow increased 62.89% from -$135.8 to -$50.4.
E
Sell
3/14/2024Downgrade
Universal Ibogaine Inc. (IBO.V) was downgraded to E+ from D- on 3/14/2024 due to a decline in the volatility index and valuation index.
Universal Ibogaine Inc. (IBO.V) was downgraded to E+ from D- on 3/14/2024 due to a decline in the volatility index and valuation index.
D
Sell
2/28/2024Upgraded
Universal Ibogaine Inc. (IBO.V) was upgraded to D- from E+ on 2/28/2024 due to an increase in the volatility index, growth index and total return index. Earnings per share increased from -$0.0011 to -$0.0008, and total revenue increased 13.28% from $420.1 to $475.9.
Universal Ibogaine Inc. (IBO.V) was upgraded to D- from E+ on 2/28/2024 due to an increase in the volatility index, growth index and total return index. Earnings per share increased from -$0.0011 to -$0.0008, and total revenue increased 13.28% from $420.1 to $475.9.
E
Sell
3/14/2023Downgrade
Universal Ibogaine Inc. (IBO.V) was downgraded to E+ from D- on 3/14/2023 due to a decline in the volatility index.
Universal Ibogaine Inc. (IBO.V) was downgraded to E+ from D- on 3/14/2023 due to a decline in the volatility index.
D
Sell
2/23/2023Upgraded
Universal Ibogaine Inc. (IBO.V) was upgraded to D- from E+ on 02/23/2023.
Universal Ibogaine Inc. (IBO.V) was upgraded to D- from E+ on 02/23/2023.
E
Sell
2/8/2023Downgrade
Universal Ibogaine Inc. (IBO.V) was downgraded to E+ from D- on 02/08/2023.
Universal Ibogaine Inc. (IBO.V) was downgraded to E+ from D- on 02/08/2023.
D
Sell
2/6/2023Downgrade
Universal Ibogaine Inc. (IBO.V) was downgraded to D- from D on 2/6/2023 due to a decline in the volatility index.
Universal Ibogaine Inc. (IBO.V) was downgraded to D- from D on 2/6/2023 due to a decline in the volatility index.
D
Sell
1/20/2023Upgraded
Universal Ibogaine Inc. (IBO.V) was upgraded to D from D- on 1/20/2023 due to a large increase in the growth index, volatility index and total return index. Earnings per share increased from -$0.0293 to -$0.0033, operating cash flow increased 74.57% from -$1.33M to -$338.5, and EBIT increased 28.28% from -$833.2 to -$597.6.
Universal Ibogaine Inc. (IBO.V) was upgraded to D from D- on 1/20/2023 due to a large increase in the growth index, volatility index and total return index. Earnings per share increased from -$0.0293 to -$0.0033, operating cash flow increased 74.57% from -$1.33M to -$338.5, and EBIT increased 28.28% from -$833.2 to -$597.6.
D
Sell
12/19/2022Upgraded
Universal Ibogaine Inc. (IBO.V) was upgraded to D- from E+ on 12/19/2022 due to an increase in the volatility index and total return index.
Universal Ibogaine Inc. (IBO.V) was upgraded to D- from E+ on 12/19/2022 due to an increase in the volatility index and total return index.
E
Sell
12/1/2022Downgrade
Universal Ibogaine Inc. (IBO.V) was downgraded to E+ from D- on 12/1/2022 due to a large decline in the growth index, solvency index and volatility index. Earnings per share declined from -$0.0049 to -$0.0293, operating cash flow declined 120.34% from -$604.1 to -$1.33M, and debt to equity increased from 0.24 to 0.44.
Universal Ibogaine Inc. (IBO.V) was downgraded to E+ from D- on 12/1/2022 due to a large decline in the growth index, solvency index and volatility index. Earnings per share declined from -$0.0049 to -$0.0293, operating cash flow declined 120.34% from -$604.1 to -$1.33M, and debt to equity increased from 0.24 to 0.44.
D
Sell
7/1/2022Upgraded
Universal Ibogaine Inc. (IBO.V) was upgraded to D- from E on 7/1/2022 due to a noticeable increase in the growth index, solvency index and valuation index. Operating cash flow increased 31.48% from -$881.6 to -$604.1.
Universal Ibogaine Inc. (IBO.V) was upgraded to D- from E on 7/1/2022 due to a noticeable increase in the growth index, solvency index and valuation index. Operating cash flow increased 31.48% from -$881.6 to -$604.1.
E
Sell
4/1/2022Upgraded
Universal Ibogaine Inc. (IBO.V) was upgraded to E from E- on 4/1/2022 due to an increase in the valuation index.
Universal Ibogaine Inc. (IBO.V) was upgraded to E from E- on 4/1/2022 due to an increase in the valuation index.
E
Sell
2/17/2022Downgrade
Universal Ibogaine Inc. (IBO.V) was downgraded to E- from E on 2/17/2022 due to a noticeable decline in the volatility index and total return index.
Universal Ibogaine Inc. (IBO.V) was downgraded to E- from E on 2/17/2022 due to a noticeable decline in the volatility index and total return index.
E
Sell
2/2/2022Upgraded
Universal Ibogaine Inc. (IBO.V) was upgraded to E from E- on 2/2/2022 due to a large increase in the efficiency index, volatility index and valuation index. Total capital increased 262.93% from $2.69M to $9.76M.
Universal Ibogaine Inc. (IBO.V) was upgraded to E from E- on 2/2/2022 due to a large increase in the efficiency index, volatility index and valuation index. Total capital increased 262.93% from $2.69M to $9.76M.
E
Sell
12/27/2021None
Universal Ibogaine Inc. (IBO.V) was downgraded to E- from U on 12/27/2021.
Universal Ibogaine Inc. (IBO.V) was downgraded to E- from U on 12/27/2021.
